Sobi Shows Positive EMBRACE Data | US FDA Grants Breakthrough Tag to Sanofi

Sanofi Updates Phase 3 CIDP Study | Novartis Hits FSHD Trial Milestone

Sanofi Psoriasis Trial Falls Short | Focus Shifts to Combination Therapies

US FDA Clears Caliway Biopharmaceuticals Phase 3 IND | MediciNova Completes MN-001 Trial

Novo Nordisk Boosts Access with ₹202/Day Ozempic & Wegovy

Gilead & Merck Show Success for Weekly HIV Pill | Caliway Unveils ADA Data

Everest Medicines Signs Deal with Corxel Pharmaceuticals for Cardamyst Nasal Spray

Hoth Therapeutics Reports Positive MASLD Data | POLY-ACS Trial Highlights Polypill Strategy

Tremfya Delivers Strong Crohn’s Data | Alebund Finishes Global Phase 3 Trial

GC Biopharma Secures IND OK in Korea for COVID-19 mRNA Vaccine Trial

Roche Advances Obesity Pipeline | Johnson & Johnson Reports Positive Lupus Data

Lundbeck Completes Enrollment in Phase 3 MASCOT Trial Ahead of Schedule

Novo Nordisk’s CagriSema bested by Lilly’s Zepbound in head-to-head trial.

Fresenius Kabi Recalls Famotidine Injection

GSK Expands Pipeline with 35Pharma Acquisition

Thermo Fisher Enrolls First Patient in PPD CorEvitas Alzheimer’s Registry

Capricor to Present at 2026 MDA Conference | Neurent NEUROMARK Trial Positive

Kidney Drug Expansion Falls Short | Ionis Steps Up Angelman Awareness Campaign

Pfizer Reports Positive GLP-1 Data at ADA | Lynk Pharmaceuticals Starts Phase 1 Trial

BlueRock’s Parkinson’s Trial Positive | Neurelis Shares Diazepam Study Data – Clinical News Update

Arletta Pharma Reports Positive Phase II Results | Eli Lilly Ebglyss Shows 4-Year Control

Sanofi Lunsekimig Hits Phase 2 Goals | Health Canada Clears Affinia Therapeutics Trial

Ananda Pharma Reports Positive Phase 1 Results for MRX1

AbbVie Files FDA NDA for Tavapadon | New Givinostat Data in DMD Unveiled – Clinical News Update

REGENXBIO Hits Duchenne Milestone | Zhimeng Launches ALS Pivotal Trial – Clinical News Update

Industry Leaders- Media coverage | Lifescience Intellipedia | Chemxpert Database | Clival Database

Probiotic Boosts Sleep | CBD Therapy Shows Early Promise

Roche Columvi Combo Delivers Sustained 3-Year Survival Benefit – Clinical News Update

$2M ALS Trial Support Announced | Ionis Wins Breakthrough Status for Zilganersen – Clinical News

Draig Begins Phase 2 for Depression | WHO Unveils New Bacterial Treatment Data– Clinical News Update

FDA Grants Authorisation for Minder®, the First and Only Implantable Continuous

Myrtelle’s Canavan Trial Success | NeuroSense Marks Alzheimer’s Progress – Clinical News Update

Tzield sBLA Gets Priority Review | Endeavor Health in Landmark Live CTE Study

CPP Phase 3 Trial Positive | Edgewise Advances EDG-7500 in Hypertrophic Cardiomyopathy

AstraZeneca Hits Phase 3 Milestone | Skye Bioscience Unveils CBeyond Results– Clinical News Update

Ascletis Gets FDA OK for ASC30 Study | AZ’s Saphnelo Shows Strong Phase III SLE Data